IPI Legacy Liquidation Co (IMPLQ)
Impel Pharmaceuticals, Inc. is a commercial-stage biopharmaceutical company. It engages in the development and commercialization of transformative therapies for patients suffering from diseases with high unmet medical needs with an initial focus on diseases of the central nervous system. The company was founded by Rodney J. Y. Ho, John D. Hoekman, and Michael P. Hite in 2008 and is headquartered in Seattle, WA.
Address
201 ELLIOTT AVE. W
SEATTLE, WA 98119
Founded
2008
Number of Employees
160
Website
http://impelpharma.com
Insider Transactions
Filters
Keyboard Shortcuts: Show (a) | Close (Esc)